Propofol versus thiopental sodium for the treatment of refractory status epilepticus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Propofol Versus Thiopental Sodium for the Treatment of Refractory Status Epilepticus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435816/1/images/google-play-badge.png. Accessed 04 May 2024.
Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/1/images/google-play-badge.png. Accessed May 4, 2024.
Propofol versus thiopental sodium for the treatment of refractory status epilepticus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/1/images/google-play-badge.png
Propofol Versus Thiopental Sodium for the Treatment of Refractory Status Epilepticus [Internet]. In: Cochrane Abstracts. [cited 2024 May 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/1/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Propofol versus thiopental sodium for the treatment of refractory status epilepticus
ID - 435816
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/1/images/google-play-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -